Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 3
1990 2
1991 3
1992 3
1993 1
1994 2
1995 1
1996 3
1997 4
1998 1
1999 6
2000 4
2001 3
2002 12
2003 5
2004 3
2005 4
2006 17
2007 15
2008 14
2009 6
2010 6
2011 11
2012 15
2013 14
2014 17
2015 24
2016 22
2017 24
2018 27
2019 15
2020 8
2021 28
2022 27
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum.
Pol S, Luzivika Nzinga C, Dorival C, Zoulim F, Cagnot C, Decaens T, Thabut D, Asselah T, Mathurin P, Ganne N, Samuel D, Habersetzer F, Bronowicki JP, Guyader D, Rosa I, Leroy V, Chazouilleres O, De Ledinghen V, Bourliere M, Causse X, Cales P, Metivier S, Loustaud-Ratti V, Abergel A, Fontaine H, Carrat F; French ANRS CO22 Hepather Cohort. Pol S, et al. Among authors: bourliere m. Aliment Pharmacol Ther. 2021 Nov;54(10):1364-1365. doi: 10.1111/apt.16661. Aliment Pharmacol Ther. 2021. PMID: 34699103 No abstract available.
Women and liver: Is woman the future of man?
Bourlière M. Bourlière M. Clin Res Hepatol Gastroenterol. 2022 Aug-Sep;46(7):101918. doi: 10.1016/j.clinre.2022.101918. Epub 2022 Apr 7. Clin Res Hepatol Gastroenterol. 2022. PMID: 35398565 No abstract available.
Non-invasive diagnosis and follow-up of autoimmune hepatitis.
Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. Lemoinne S, et al. Among authors: bourliere m. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101772. doi: 10.1016/j.clinre.2021.101772. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332126 Review.
Chronic hepatitis C: future treatment.
Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M. Wendt A, et al. Among authors: bourliere m. Clin Pharmacol. 2014 Jan 8;6:1-17. doi: 10.2147/CPAA.S30338. eCollection 2014. Clin Pharmacol. 2014. PMID: 24470777 Free PMC article. Review.
Non-invasive diagnosis and follow-up of hyperferritinaemia.
Bardou-Jacquet E, Hamdi-Roze H, Paisant A, Decraecker M, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C. Bardou-Jacquet E, et al. Among authors: bourliere m. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101762. doi: 10.1016/j.clinre.2021.101762. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332132
Sofosbuvir as backbone of interferon free treatments.
Bourlière M, Oules V, Ansaldi C, Adhoute X, Castellani P. Bourlière M, et al. Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S212-20. doi: 10.1016/j.dld.2014.09.024. Epub 2014 Nov 6. Dig Liver Dis. 2014. PMID: 25453869 Free article. Review.
Hepatitis C virus therapy: No one will be left behind.
Bourlière M, Pietri O. Bourlière M, et al. Int J Antimicrob Agents. 2019 Jun;53(6):755-760. doi: 10.1016/j.ijantimicag.2018.12.010. Epub 2018 Dec 31. Int J Antimicrob Agents. 2019. PMID: 30605721 Review.
301 results